Tillkännagivande • Aug 03
Indokem Limited, Annual General Meeting, Sep 24, 2026 Indokem Limited, Annual General Meeting, Sep 24, 2026, at 14:00 Indian Standard Time. Reported Earnings • Aug 03
First quarter 2027 earnings released: EPS: ₹0.38 (vs ₹0.25 in 1Q 2026) First quarter 2027 results: EPS: ₹0.38 (up from ₹0.25 in 1Q 2026). Revenue: ₹469.2m (up 13% from 1Q 2026). Net income: ₹10.7m (up 53% from 1Q 2026). Profit margin: 2.3% (up from 1.7% in 1Q 2026). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 80% per year but the company’s share price has increased by 88% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Aug 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 3 highly experienced directors. MD & Director Arupkumar Basu was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Tillkännagivande • Jul 24
Indokem Limited to Report Q1, 2027 Results on Jul 31, 2026 Indokem Limited announced that they will report Q1, 2027 results on Jul 31, 2026 New Risk • May 18
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.1% Last year net profit margin: 1.8% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. This is currently the only risk that has been identified for the company. Tillkännagivande • Apr 29
Indokem Limited to Report Q4, 2026 Results on May 04, 2026 Indokem Limited announced that they will report Q4, 2026 results on May 04, 2026 New Risk • Mar 22
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Reported Earnings • Jan 31
Third quarter 2026 earnings released: EPS: ₹0.15 (vs ₹0.26 in 3Q 2025) Third quarter 2026 results: EPS: ₹0.15 (down from ₹0.26 in 3Q 2025). Revenue: ₹441.0m (up 1.6% from 3Q 2025). Net income: ₹4.10m (down 45% from 3Q 2025). Profit margin: 0.9% (down from 1.7% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has increased by 77% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Jan 22
Indokem Limited to Report Q3, 2026 Results on Jan 30, 2026 Indokem Limited announced that they will report Q3, 2026 results on Jan 30, 2026 New Risk • Dec 15
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Reported Earnings • Nov 18
Second quarter 2026 earnings released Second quarter 2026 results: EPS: ₹0.15. Revenue: ₹403.0m (down 6.9% from 2Q 2025). Net income: ₹4.10m (up ₹4.10m from 2Q 2025). Profit margin: 1.0% (up from 0% in 2Q 2025). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has increased by 102% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Nov 05
Indokem Limited to Report Q2, 2026 Results on Nov 13, 2025 Indokem Limited announced that they will report Q2, 2026 results on Nov 13, 2025 Reported Earnings • Aug 09
First quarter 2026 earnings released: EPS: ₹0.25 (vs ₹0.50 loss in 1Q 2025) First quarter 2026 results: EPS: ₹0.25 (up from ₹0.50 loss in 1Q 2025). Revenue: ₹417.4m (up 13% from 1Q 2025). Net income: ₹7.00m (up ₹20.8m from 1Q 2025). Profit margin: 1.7% (up from net loss in 1Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 78% per year, which means it is well ahead of earnings. Tillkännagivande • Aug 08
Indokem Limited, Annual General Meeting, Sep 25, 2025 Indokem Limited, Annual General Meeting, Sep 25, 2025, at 14:00 Indian Standard Time. Tillkännagivande • Aug 02
Indokem Limited to Report Q1, 2026 Results on Aug 08, 2025 Indokem Limited announced that they will report Q1, 2026 results on Aug 08, 2025 New Risk • Jul 24
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.2% average weekly change). Minor Risk Market cap is less than US$100m (₹8.46b market cap, or US$98.1m). New Risk • Jun 12
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.0% average weekly change). Market cap is less than US$100m (₹6.85b market cap, or US$80.1m). Tillkännagivande • May 01
Indokem Limited to Report Q4, 2025 Results on May 09, 2025 Indokem Limited announced that they will report Q4, 2025 results on May 09, 2025 Reported Earnings • Feb 08
Third quarter 2025 earnings released: EPS: ₹0.26 (vs ₹0.05 loss in 3Q 2024) Third quarter 2025 results: EPS: ₹0.26 (up from ₹0.05 loss in 3Q 2024). Revenue: ₹440.5m (up 9.4% from 3Q 2024). Net income: ₹7.40m (up ₹8.70m from 3Q 2024). Profit margin: 1.7% (up from net loss in 3Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 137 percentage points per year, which is a significant difference in performance. Tillkännagivande • Jan 30
Indokem Limited to Report Q3, 2025 Results on Feb 07, 2025 Indokem Limited announced that they will report Q3, 2025 results at 12:15 PM, Indian Standard Time on Feb 07, 2025 New Risk • Dec 30
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 44% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Market cap is less than US$100m (₹2.79b market cap, or US$32.7m). Reported Earnings • Nov 18
Second quarter 2025 earnings released Second quarter 2025 results: Revenue: ₹433.4m (up 7.4% from 2Q 2024). Net income: ₹0 (up ₹46.5m from 2Q 2024). Profit margin: 0% (up from net loss in 2Q 2024). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 141 percentage points per year, which is a significant difference in performance. Tillkännagivande • Nov 06
Indokem Limited to Report Q2, 2025 Results on Nov 14, 2024 Indokem Limited announced that they will report Q2, 2025 results on Nov 14, 2024 Reported Earnings • Aug 14
First quarter 2025 earnings released: ₹0.50 loss per share (vs ₹0.27 loss in 1Q 2024) First quarter 2025 results: ₹0.50 loss per share (further deteriorated from ₹0.27 loss in 1Q 2024). Revenue: ₹369.9m (up 19% from 1Q 2024). Net loss: ₹13.8m (loss widened 112% from 1Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 156 percentage points per year, which is a significant difference in performance. Tillkännagivande • Aug 13
Indokem Limited, Annual General Meeting, Sep 26, 2024 Indokem Limited, Annual General Meeting, Sep 26, 2024, at 14:00 Indian Standard Time. Tillkännagivande • Aug 07
Indokem Limited to Report Q1, 2025 Results on Aug 13, 2024 Indokem Limited announced that they will report Q1, 2025 results on Aug 13, 2024 New Risk • Jun 14
New major risk - Revenue and earnings growth Earnings have declined by 18% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 18% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.0% average weekly change). Shareholders have been diluted in the past year (15% increase in shares outstanding). Market cap is less than US$100m (₹2.79b market cap, or US$33.4m). New Risk • May 31
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Shareholders have been diluted in the past year (15% increase in shares outstanding). Market cap is less than US$100m (₹2.25b market cap, or US$27.0m). Tillkännagivande • May 24
Indokem Limited to Report Q4, 2024 Results on May 30, 2024 Indokem Limited announced that they will report Q4, 2024 results on May 30, 2024 Reported Earnings • Feb 14
Third quarter 2024 earnings released: ₹0.05 loss per share (vs ₹0.25 profit in 3Q 2023) Third quarter 2024 results: ₹0.05 loss per share (down from ₹0.25 profit in 3Q 2023). Revenue: ₹403.1m (up 40% from 3Q 2023). Net loss: ₹1.30m (down 122% from profit in 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 159 percentage points per year, which is a significant difference in performance. Tillkännagivande • Feb 13
Indokem Limited Announces Board Changes Indokem Limited announced Mr. Kailash Pershad and Mr. Bhalchandra Sontakke will complete their second and final term as an independent Directors of the Company and consequently will cease to be independent Directors on the Board of the Company w.e.f. close of business hours on 31st March, 2024. Tillkännagivande • Feb 06
Indokem Limited to Report Q3, 2024 Results on Feb 13, 2024 Indokem Limited announced that they will report Q3, 2024 results on Feb 13, 2024 Reported Earnings • Nov 11
Second quarter 2024 earnings released: ₹1.67 loss per share (vs ₹0.20 profit in 2Q 2023) Second quarter 2024 results: ₹1.67 loss per share (down from ₹0.20 profit in 2Q 2023). Revenue: ₹405.5m (up 39% from 2Q 2023). Net loss: ₹46.5m (down ₹51.4m from profit in 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 182 percentage points per year, which is a significant difference in performance. New Risk • Oct 14
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 15% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.0x net interest cover). Minor Risks Shareholders have been diluted in the past year (15% increase in shares outstanding). Market cap is less than US$100m (₹3.02b market cap, or US$36.3m). Tillkännagivande • Oct 01
Indokem Limited Announces Appointment of Arupkumar Basu as a Managing Director Indokem Limited announced that Mr. Arupkumar Basu, Non-executive Director of the Company has been appointed as Managing Director of the Company at the meeting of the Board of Directors of the Company held on 25th July, 2023 and approved by the shareholders at the 57th Annual General Meeting of the Company held on 31st August, 2023 with effect from the date of the scheme of amalgamation between the Company and Refnol Resins and Chemicals Limited becoming effective for the period of 3 consecutive years. The said scheme of amalgamation between the Company and Refnol Resins and Chemicals Limited has become effective from 29th September, 2023 after filing of necessary forms with Ministry of Corporate Affairs /Registrar of Companies, Mumbai on 29th September, 2023. Mr. Arup Kumar Basu (DIN: 00906760) is a B. Tech, Chemical Engineering from IIT, Bombay and has obtained a postgraduate management degree from IIM, Ahmedabad. and has an experience of over 40 years in this industry. Board Change • Aug 12
High number of new directors Additional Non-Executive Director Arupkumar Basu was the last director to join the board, commencing their role in 2023. Tillkännagivande • Jul 26
Indokem Limited, Annual General Meeting, Aug 31, 2023 Indokem Limited, Annual General Meeting, Aug 31, 2023, at 14:00 Indian Standard Time. Reported Earnings • Jul 26
First quarter 2024 earnings released: ₹0.27 loss per share (vs ₹0.49 loss in 1Q 2023) First quarter 2024 results: ₹0.27 loss per share (improved from ₹0.49 loss in 1Q 2023). Revenue: ₹312.2m (up 20% from 1Q 2023). Net loss: ₹6.50m (loss narrowed 45% from 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has increased by 116% per year, which means it is well ahead of earnings. Tillkännagivande • May 13
Indokem Limited to Report Q4, 2023 Results on May 22, 2023 Indokem Limited announced that they will report Q4, 2023 results at 3:30 PM, Indian Standard Time on May 22, 2023 Reported Earnings • Feb 10
Third quarter 2023 earnings released: EPS: ₹0.25 (vs ₹0.64 in 3Q 2022) Third quarter 2023 results: EPS: ₹0.25 (down from ₹0.64 in 3Q 2022). Revenue: ₹289.9m (down 15% from 3Q 2022). Net income: ₹6.00m (down 62% from 3Q 2022). Profit margin: 2.1% (down from 4.6% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has increased by 126% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Feb 03
Indokem Limited to Report Q3, 2023 Results on Feb 09, 2023 Indokem Limited announced that they will report Q3, 2023 results on Feb 09, 2023 Reported Earnings • Nov 16
Second quarter 2023 earnings released: EPS: ₹0.21 (vs ₹0.08 in 2Q 2022) Second quarter 2023 results: EPS: ₹0.21 (up from ₹0.08 in 2Q 2022). Revenue: ₹297.5m (up 22% from 2Q 2022). Net income: ₹4.90m (up 158% from 2Q 2022). Profit margin: 1.6% (up from 0.8% in 2Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has increased by 160% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Nov 05
Indokem Limited to Report Q2, 2023 Results on Nov 11, 2022 Indokem Limited announced that they will report Q2, 2023 results at 3:00 PM, Indian Standard Time on Nov 11, 2022 Reported Earnings • Aug 11
First quarter 2023 earnings released: ₹0.49 loss per share (vs ₹0.20 profit in 1Q 2022) First quarter 2023 results: ₹0.49 loss per share (down from ₹0.20 profit in 1Q 2022). Revenue: ₹268.8m (up 11% from 1Q 2022). Net loss: ₹11.8m (down 341% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has increased by 118% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Aug 10
Indokem Limited, Annual General Meeting, Sep 29, 2022 Indokem Limited, Annual General Meeting, Sep 29, 2022, at 15:00 Indian Standard Time. Valuation Update With 7 Day Price Move • Jun 24
Investor sentiment improved over the past week After last week's 16% share price gain to ₹69.60, the stock trades at a trailing P/E ratio of 59.8x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 658% over the past three years. Reported Earnings • May 30
Full year 2022 earnings released: EPS: ₹1.16 (vs ₹1.22 in FY 2021) Full year 2022 results: EPS: ₹1.16 (down from ₹1.22 in FY 2021). Revenue: ₹1.14b (up 44% from FY 2021). Net income: ₹28.3m (down 4.4% from FY 2021). Profit margin: 2.5% (down from 3.7% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 89% per year but the company’s share price has only increased by 75% per year, which means it is significantly lagging earnings growth. Tillkännagivande • May 19
Indokem Limited to Report Q4, 2022 Results on May 26, 2022 Indokem Limited announced that they will report Q4, 2022 results on May 26, 2022 Valuation Update With 7 Day Price Move • Apr 13
Investor sentiment improved over the past week After last week's 17% share price gain to ₹58.50, the stock trades at a trailing P/E ratio of 45.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 408% over the past three years. Valuation Update With 7 Day Price Move • Jan 21
Investor sentiment improved over the past week After last week's 47% share price gain to ₹58.05, the stock trades at a trailing P/E ratio of 48.4x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 317% over the past three years. Valuation Update With 7 Day Price Move • Dec 10
Investor sentiment improved over the past week After last week's 17% share price gain to ₹40.85, the stock trades at a trailing P/E ratio of 34x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 158% over the past three years. Reported Earnings • Nov 03
Second quarter 2022 earnings released: EPS ₹0.08 (vs ₹0.27 in 2Q 2021) The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2022 results: Revenue: ₹244.3m (up 23% from 2Q 2021). Net income: ₹1.90m (down 71% from 2Q 2021). Profit margin: 0.8% (down from 3.3% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Sep 16
Investor sentiment improved over the past week After last week's 19% share price gain to ₹39.80, the stock trades at a trailing P/E ratio of 28.6x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 72% over the past three years. Reported Earnings • Aug 18
First quarter 2022 earnings released: EPS ₹0.20 (vs ₹0.02 in 1Q 2021) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹245.1m (up 159% from 1Q 2021). Net income: ₹4.90m (up ₹4.30m from 1Q 2021). Profit margin: 2.0% (up from 0.6% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jul 30
Investor sentiment deteriorated over the past week After last week's 17% share price decline to ₹39.40, the stock trades at a trailing P/E ratio of 32.3x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 142% over the past three years. Valuation Update With 7 Day Price Move • Jul 14
Investor sentiment improved over the past week After last week's 16% share price gain to ₹46.90, the stock trades at a trailing P/E ratio of 38.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 235% over the past three years. Valuation Update With 7 Day Price Move • Jun 11
Investor sentiment improved over the past week After last week's 16% share price gain to ₹37.85, the stock trades at a trailing P/E ratio of 31x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 137% over the past three years. Reported Earnings • May 29
Full year 2021 earnings released: EPS ₹1.22 (vs ₹0.21 in FY 2020) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: ₹794.7m (down 11% from FY 2020). Net income: ₹29.6m (up 480% from FY 2020). Profit margin: 3.7% (up from 0.6% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 96% per year but the company’s share price has only increased by 27% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • May 05
Investor sentiment improved over the past week After last week's 17% share price gain to ₹36.85, the stock trades at a trailing P/E ratio of 30.5x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 92% over the past three years. Valuation Update With 7 Day Price Move • Apr 12
Investor sentiment improved over the past week After last week's 17% share price gain to ₹28.60, the stock trades at a trailing P/E ratio of 23.7x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 35% over the past three years. Reported Earnings • Feb 17
Third quarter 2021 earnings released: EPS ₹0.56 (vs ₹0.23 in 3Q 2020) The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₹222.3m (down 2.9% from 3Q 2020). Net income: ₹13.6m (up 139% from 3Q 2020). Profit margin: 6.1% (up from 2.5% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Tillkännagivande • Feb 03
Indokem Limited to Report Q3, 2021 Results on Feb 12, 2021 Indokem Limited announced that they will report Q3, 2021 results on Feb 12, 2021 Valuation Update With 7 Day Price Move • Jan 15
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₹23.45, the stock is trading at a trailing P/E ratio of 26.7x, down from the previous P/E ratio of 31.8x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 26%. Valuation Update With 7 Day Price Move • Jan 01
Investor sentiment improved over the past week After last week's 21% share price gain to ₹22.30, the stock is trading at a trailing P/E ratio of 25.4x, up from the previous P/E ratio of 21x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 37%. Is New 90 Day High Low • Dec 29
New 90-day high: ₹19.63 The company is up 70% from its price of ₹11.56 on 30 September 2020. The Indian market is up 21% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period. Valuation Update With 7 Day Price Move • Dec 16
Investor sentiment improved over the past week After last week's 23% share price gain to ₹19.09, the stock is trading at a trailing P/E ratio of 21.7x, up from the previous P/E ratio of 17.7x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 39%. Valuation Update With 7 Day Price Move • Dec 08
Market bids up stock over the past week After last week's 19% share price gain to ₹15.12, the stock is trading at a trailing P/E ratio of 17.2x, up from the previous P/E ratio of 14.5x. This compares to an average P/E of 17x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 47%. Is New 90 Day High Low • Dec 07
New 90-day high: ₹13.80 The company is up 17% from its price of ₹11.84 on 07 September 2020. The Indian market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period. Reported Earnings • Nov 12
Second quarter 2021 earnings released: EPS ₹0.27 The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: ₹199.5m (down 18% from 2Q 2020). Net income: ₹6.60m (up 408% from 2Q 2020). Profit margin: 3.3% (up from 0.5% in 2Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Oct 16
Market bids up stock over the past week After last week's 15% share price gain to ₹12.55, the stock is trading at a trailing P/E ratio of 20.1x, up from the previous P/E ratio of 17.4x. This compares to an average P/E of 15x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 64%. Tillkännagivande • Aug 20
Indokem Limited to Report Q1, 2021 Results on Aug 25, 2020 Indokem Limited announced that they will report Q1, 2021 results on Aug 25, 2020 Tillkännagivande • Jul 10
Indokem Limited to Report Q4, 2020 Results on Jul 16, 2020 Indokem Limited announced that they will report Q4, 2020 results on Jul 16, 2020 
